ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,749Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 231

$491K Total Retail Price of All Prescriptions

Rank: 30 out of 231

475 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 5,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LEVOTHYROXINE SODIUM 326 240 1 3
METFORMIN HCL 314 220 2 7
LISINOPRIL 290 214 3 1
AMLODIPINE BESYLATE 284 259 4 4
ATORVASTATIN CALCIUM 237 150 5 8
PRAVASTATIN SODIUM 230 189 6 10
SIMVASTATIN 224 153 7 2
GLIMEPIRIDE 163 144 8 38
LOSARTAN POTASSIUM 152 118 9 29
OMEPRAZOLE 151 92 10 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 107 11 22
FUROSEMIDE 139 113 12 6
HYDROCHLOROTHIAZIDE 134 102 13 9
TRAMADOL HCL 132 78 14 16
FELODIPINE ER 113 94 15 126
CRESTOR 110 79 16 19
ATENOLOL 101 95 17 11
HYDROCODONE-ACETAMINOPHEN 99 47 S3 18 21
DOXAZOSIN MESYLATE 83 83 19 105
ZOLPIDEM TARTRATE 82 51 20 14
CLOPIDOGREL 78 64 21 44
PAROXETINE HCL 77 56 22 70
LOSARTAN-HYDROCHLOROTHIAZIDE 73 49 23 101
PLAVIX 71 63 24 60
ALLOPURINOL 67 60 25 48
CARVEDILOL 63 49 26 24
METOPROLOL SUCCINATE 62 48 27 13
TAMSULOSIN HCL 55 51 28 30
SPIRIVA 55 47 28 61
OXYCODONE HCL 53 11 S2 30 23
LIPITOR 53 31 30 97
PREDNISONE 53 36 30 41
AMLODIPINE BESYLATE-BENAZEPRIL 52 39 33 94
ZETIA 51 35 34 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.